BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:24 PM
 | 
Apr 09, 2008
 |  BC Extra  |  Clinical News

Hivenyl meets Phase II endpoint in CIU

Barrier (NASDAQ:BTRX) said Hivenyl met the primary endpoint of a significant decrease from baseline in average itch severity scores vs....

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >